Table 2 Disease-specific comorbidities of patients with and without SPS/CPS use
Non-acute outpatient treated HK patients (cohort 1a) (N = 3333) | Chronic HK patients (cohort 1b) (N = 1693) | |||||||
|---|---|---|---|---|---|---|---|---|
Patients with ≥1 SPS/CPS prescription | Patients without SPS/CPS prescription | Patients with ≥1 SPS/CPS prescription | Patients without SPS/CPS prescription | |||||
n | % | n | % | n | % | n | % | |
Chronic kidney disease (most severe diagnosis coding was taken into account) | ||||||||
CKD stage 1 & 2 | 12 | 1.3 | 102 | 4.2 | < 5 | NA | 51 | 3.8 |
CKD stage 3 | 139 | 15.6 | 395 | 16.2 | 59 | 16.6 | 193 | 14.4 |
CKD stage 4 | 198 | 22.2 | 245 | 10.0 | 102 | 28.7 | 134 | 10.0 |
CKD stage 5 without dialysis | 55 | 6.2 | 63 | 2.6 | 21 | 5.9 | 42 | 3.1 |
CKD stage 5 with dialysis | 317 | 35.6 | 211 | 8.6 | 97 | 27.2 | 157 | 11.7 |
CKD (distinct) | 721 | 80.9 | 1016 | 41.6 | 283 | 79.5 | 577 | 43.2 |
Heart failure (most severe diagnosis coding was taken into account) | ||||||||
Heart failure NYHA class I | 14 | 1.6 | 26 | 1.1 | < 5 | NA | 17 | 1.3 |
Heart failure NYHA class II | 51 | 5.7 | 108 | 4.4 | 21 | 5.9 | 61 | 4.6 |
Heart failure NYHA class III | 57 | 6.4 | 149 | 6.1 | 16 | 4.5 | 88 | 6.6 |
Heart failure NYHA class IV | 63 | 7.1 | 136 | 5.6 | 19 | 5.3 | 64 | 4.8 |
Heart failure unspecified | 21 | 2.4 | 56 | 2.3 | 6 | 1.7 | 24 | 1.8 |
Heart failure (distinct) | 206 | 23.1 | 475 | 19.5 | 66 | 18.5 | 254 | 19.0 |